Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: current status.

Deeg, H Joachim; Bartenstein, Matthias

Deeg, H Joachim; Bartenstein, Matthias.

Affiliation

Deeg HJ; Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. jdeeg@fhcrc.org

Arch Immunol Ther Exp (Warsz) ; 60(1): 31-41, 2012 Feb.

Article in En | MEDLINE | ID: mdl-22143157

Subject(s)

Hematopoietic Stem Cell Transplantation/methods; Myelodysplastic Syndromes/surgery; Cytogenetic Analysis; Disease-Free Survival; Humans; Myelodysplastic Syndromes/pathology; Myelodysplastic Syndromes/physiopathology; Recurrence; Risk Factors; Tissue Donors; Transplantation Conditioning/methods; Transplantation, Homologous; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Arch Immunol Ther Exp (Warsz) Year: 2012 Document type: Article

Fulltext

XML

PubMed Links

Search on Google